Growth Metrics

Innoviva (INVA) Raw Materials (2012 - 2026)

Innoviva posted quarterly Raw Materials of $17.5 million for Q1 2026, up 64.44% year-on-year from $10.6 million in Q1 2025, and up 6.93% on a QoQ basis from $16.3 million in Q4 2025.

Innoviva (INVA) has 8 years of Raw Materials data on file, last reported at $17.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Raw Materials rose 64.44% year-over-year to $17.5 million; the trailing twelve-month figure through Mar 2026 stood at $17.5 million (up 64.44% YoY), and the FY2025 full-year result was $16.3 million, up 46.95% from the prior year.
  • Raw Materials for Q1 2026 stood at $17.5 million, up from $16.3 million in the prior quarter.
  • Across five years, Raw Materials topped out at $17.5 million in Q1 2026 and bottomed at $5.8 million in Q3 2022.
  • The 5-year median for Raw Materials is $9.5 million (2024), against an average of $10.4 million.
  • The widest annual swing landed in 2023, when Raw Materials surged 95.54%; it then slipped 1.28% in 2024.
  • A 5-year view of Raw Materials shows it stood at $5.8 million in 2022, then soared by 95.54% to $11.3 million in 2023, then dropped by 1.28% to $11.1 million in 2024, then jumped by 46.95% to $16.3 million in 2025, then grew by 6.93% to $17.5 million in 2026.
  • The last three Raw Materials figures came in at $17.5 million (Q1 2026), $16.3 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17.46 Mn
Dec 31, 2025 16.33 Mn
Sep 30, 2025 14.37 Mn
Jun 30, 2025 10.55 Mn
Mar 31, 2025 10.62 Mn
Dec 31, 2024 11.11 Mn
Sep 30, 2024 9.53 Mn
Jun 30, 2024 9.53 Mn
Mar 31, 2024 9.53 Mn
Dec 31, 2023 11.26 Mn
Sep 30, 2023 8.86 Mn
Jun 30, 2023 8.86 Mn
Mar 31, 2023 5.76 Mn
Dec 31, 2022 5.76 Mn
Sep 30, 2022 5.76 Mn
Mar 31, 2014 4.00 Mn
Dec 31, 2013 5.14 Mn
Sep 30, 2013 4.08 Mn
Jun 30, 2013 3.53 Mn
Mar 31, 2013 8.05 Mn
Dec 31, 2012 5.67 Mn
Sep 30, 2012 5.15 Mn
Jun 30, 2012 4.30 Mn